Antibiotics by diagnosis: Difference between revisions
No edit summary |
No edit summary |
||
| Line 4: | Line 4: | ||
==CNS== | ==CNS== | ||
===[[Meningitis]]=== | |||
== | |||
Vancomycin 750mg (15mg/kg) IV | Vancomycin 750mg (15mg/kg) IV | ||
| Line 48: | Line 15: | ||
Ampicillin 2g (50mg/kg) IV ''if concern for Listeria'' | Ampicillin 2g (50mg/kg) IV ''if concern for Listeria'' | ||
==ENT== | |||
===[[Otitis Media]]=== | |||
Amoxicillin 500mg (45mg/kg) PO Q12 | Amoxicillin 500mg (45mg/kg) PO Q12 | ||
| Line 61: | Line 28: | ||
Cefdinir 600mg (14mg/kg) PO Daily | Cefdinir 600mg (14mg/kg) PO Daily | ||
===[[Otitis Externa]]=== | |||
Ciprodex 3gtt Q12 | Ciprodex 3gtt Q12 | ||
| Line 70: | Line 35: | ||
Polysporin otic 5gtt Q6 | Polysporin otic 5gtt Q6 | ||
===[[Pharyngitis]]=== | |||
Bicillin 1.2 million units (25k/kg) IM | Bicillin 1.2 million units (25k/kg) IM | ||
| Line 79: | Line 42: | ||
Azithromycin 500mg (12mg/kg) PO Daily | Azithromycin 500mg (12mg/kg) PO Daily | ||
==Eye== | |||
===[[Corneal Abrasion]]=== | |||
Erythromycin ophthalmic Q6 | Erythromycin ophthalmic Q6 | ||
| Line 88: | Line 52: | ||
Levofloxacin 0.5% 2gtt Q2 ''if patient is a contact user'' | Levofloxacin 0.5% 2gtt Q2 ''if patient is a contact user'' | ||
===[[Orbital Cellulitis]]=== | |||
Vancomycin 1g (15mg/kg) IV Q12<br> | |||
==GI== | |||
===[[Appendicitis]]=== | |||
Zosyn 4.5g (100 mg/kg) IV Q6 | Zosyn 4.5g (100 mg/kg) IV Q6 | ||
| Line 104: | Line 67: | ||
Ciprofloxacin 400mg IV Q12 | Ciprofloxacin 400mg IV Q12 | ||
===[[Cholecystitis]]=== | |||
Augmentin 3g IV Q6 | Augmentin 3g IV Q6 | ||
| Line 113: | Line 74: | ||
Imipenem/Cilastin 500mg IV Q6 | Imipenem/Cilastin 500mg IV Q6 | ||
===[[Diverticulitis]]=== | |||
Flagyl 500mg PO Q6 | Flagyl 500mg PO Q6 | ||
| Line 122: | Line 81: | ||
Ciprofloxacin 750mg PO Q12 | Ciprofloxacin 750mg PO Q12 | ||
===Infectious [[Diarrhea]]=== | |||
Empiric: Cipro 500mg PO Q12 x3d | Empiric: Cipro 500mg PO Q12 x3d | ||
| Line 131: | Line 88: | ||
C. diff: Flagyl 500mg PO Q8 x14d | C. diff: Flagyl 500mg PO Q8 x14d | ||
==GU== | |||
===[[Epididymitis]]=== | |||
Age <35 (gonorrhea suspected): | Age <35 (gonorrhea suspected): | ||
| Line 146: | Line 102: | ||
Ciprofloxacin 500mg PO Q12 x14d | Ciprofloxacin 500mg PO Q12 x14d | ||
===[[Cervicitis]]/[[Urethritis]]=== | |||
Cefixime 400mg PO once | Cefixime 400mg PO once | ||
| Line 159: | Line 113: | ||
Flagyl 2g PO once ''if concern for trichomoniasis'' | Flagyl 2g PO once ''if concern for trichomoniasis'' | ||
===[[PID]]=== | |||
Ceftriaxone 250mg 1M once | Ceftriaxone 250mg 1M once | ||
| Line 168: | Line 120: | ||
Doxycycline 100 mg PO Q12 x14d | Doxycycline 100 mg PO Q12 x14d | ||
===[[UTI]]=== | |||
Macrobid 100mg PO BID x7d | Macrobid 100mg PO BID x7d | ||
| Line 181: | Line 131: | ||
Keflex 500mg PO Q6 x7d | Keflex 500mg PO Q6 x7d | ||
==Pulmonary== | |||
===[[Pneumonia]]=== | |||
Outpatient: | Outpatient: | ||
| Line 212: | Line 162: | ||
Tobramycin 4mg/kg IV ''(Pseudomonas)'' | Tobramycin 4mg/kg IV ''(Pseudomonas)'' | ||
==Skin and Soft Tissue== | |||
===[[Cellulitis]]/Superficial [[Abscess]]=== | |||
Bactrim DS 2tab PO Q12 x5-10d | Bactrim DS 2tab PO Q12 x5-10d | ||
| Line 237: | Line 186: | ||
Zosyn 3.375g IV | Zosyn 3.375g IV | ||
==Bioterrorism== | |||
==Environmental Exposure== | |||
==Immunocompromised== | |||
===[[Neutropenic Fever]]=== | |||
Zosyn 4.5g IV | Zosyn 4.5g IV | ||
| Line 254: | Line 206: | ||
Vancomycin 1g IV ''for catheter related infection, colonization with MRSA, gram-positive culture unknown susceptibility, suspected sepsis'' | Vancomycin 1g IV ''for catheter related infection, colonization with MRSA, gram-positive culture unknown susceptibility, suspected sepsis'' | ||
==Post Exposure Prophylaxis== | |||
==Pediatric== | |||
==Sepsis== | |||
*See [[Initial Antibiotics in Sepsis (Main)]] | |||
==Arthropod and Parasitic Infections== | |||
== See Also == | == See Also == | ||
Revision as of 00:22, 11 February 2014
Bone and Joint
Cardiovascular
CNS
Meningitis
Vancomycin 750mg (15mg/kg) IV
PLUS
Ceftriaxone 2g (50mg/kg) IV
ADD
Ampicillin 2g (50mg/kg) IV if concern for Listeria
ENT
Otitis Media
Amoxicillin 500mg (45mg/kg) PO Q12
OR
Augmentin 500mg (45mg/kg) PO Q12
OR
Cefdinir 600mg (14mg/kg) PO Daily
Otitis Externa
Ciprodex 3gtt Q12
OR
Polysporin otic 5gtt Q6
Pharyngitis
Bicillin 1.2 million units (25k/kg) IM
OR
Azithromycin 500mg (12mg/kg) PO Daily
Eye
Corneal Abrasion
Erythromycin ophthalmic Q6
OR
Levofloxacin 0.5% 2gtt Q2 if patient is a contact user
Orbital Cellulitis
Vancomycin 1g (15mg/kg) IV Q12
GI
Appendicitis
Zosyn 4.5g (100 mg/kg) IV Q6
OR
Flagyl 500mg (7.5mg/kg) IV Q6
PLUS
Ciprofloxacin 400mg IV Q12
Cholecystitis
Augmentin 3g IV Q6
OR
Imipenem/Cilastin 500mg IV Q6
Diverticulitis
Flagyl 500mg PO Q6
PLUS
Ciprofloxacin 750mg PO Q12
Infectious Diarrhea
Empiric: Cipro 500mg PO Q12 x3d
Giardia: Flagyl 500mg PO Q8 x5d
C. diff: Flagyl 500mg PO Q8 x14d
GU
Epididymitis
Age <35 (gonorrhea suspected):
Doxycycline 100mg PO Q12 x14d
PLUS
Cefixime 400mg PO once
Age >35 (gonorrhea not suspected):
Ciprofloxacin 500mg PO Q12 x14d
Cervicitis/Urethritis
Cefixime 400mg PO once
OR
Azithromycin 1g PO once
ADD
Flagyl 2g PO once if concern for trichomoniasis
PID
Ceftriaxone 250mg 1M once
PLUS
Doxycycline 100 mg PO Q12 x14d
UTI
Macrobid 100mg PO BID x7d
OR
Bactrim DS PO Q12 x3d
OR
Keflex 500mg PO Q6 x7d
Pulmonary
Pneumonia
Outpatient:
Azithromycin 500mg PO, 250mg PO x3d
OR
Doxycycline 100mg PO Q12 x7d
Inpatient, Community Acquired
Ceftriaxone 1g IV
PLUS
Azithromycin 500mg IV
Inpatient, Health Care Acquired
Vancomycin 1g IV (MRSA)
PLUS
Cefepime 2g IV (Pseudomonas)
PLUS
Tobramycin 4mg/kg IV (Pseudomonas)
Skin and Soft Tissue
Cellulitis/Superficial Abscess
Bactrim DS 2tab PO Q12 x5-10d
PLUS
Cephalexin 500mg PO Q6 x5-10
OR
Clindamycin 450mg PO Q8 x5-10d
Diabetic with systemic toxicity
Vancomycin 1g IV
PLUS
Unasyn 3g IV
OR
Zosyn 3.375g IV
Bioterrorism
Environmental Exposure
Immunocompromised
Neutropenic Fever
Zosyn 4.5g IV
OR
Meropenem 1g IV
PLUS/MINUS
Gentamicin 2mg/kg IV
ADD
Vancomycin 1g IV for catheter related infection, colonization with MRSA, gram-positive culture unknown susceptibility, suspected sepsis
Post Exposure Prophylaxis
Pediatric
Sepsis
Arthropod and Parasitic Infections
See Also
Source
- CURRENT Medical Dx & Tx
- University of Cincinnati Department of Emergency Medicine "Handbook of EM Fundamentals"
